KR102083003B1 - Composition having improvement activity of scalp and hair using compound extract - Google Patents

Composition having improvement activity of scalp and hair using compound extract Download PDF

Info

Publication number
KR102083003B1
KR102083003B1 KR1020180096659A KR20180096659A KR102083003B1 KR 102083003 B1 KR102083003 B1 KR 102083003B1 KR 1020180096659 A KR1020180096659 A KR 1020180096659A KR 20180096659 A KR20180096659 A KR 20180096659A KR 102083003 B1 KR102083003 B1 KR 102083003B1
Authority
KR
South Korea
Prior art keywords
hair
extract
effect
scalp
composition
Prior art date
Application number
KR1020180096659A
Other languages
Korean (ko)
Inventor
박경래
Original Assignee
박경래
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박경래 filed Critical 박경래
Priority to KR1020180096659A priority Critical patent/KR102083003B1/en
Application granted granted Critical
Publication of KR102083003B1 publication Critical patent/KR102083003B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/235Foeniculum (fennel)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a composition having an effect of improving scalp and hair conditions. The composition comprises, as an active ingredient, 0.15 to 5.00 wt% of a complex extract in which a Hydrangea serrata leaf extract, Arnica montana flower extract, Foeniculum vulgare extract, Scutellaria baicalensis extract, Matricaria chamomilla flower extract, Paeonia suffruticosa root extract, salvia extract, and Calendula officinalis flower extract are mixed, based on a total weight of a formulation for scalp and hair. The composition has a hair moisturizing effect, anti-splitting effect and softening effect, suppresses the excessive production of sebum associated with alopecia, has an anti-hair loss effect, a hair growth effect, and a strong antibacterial action against dandruff bacteria, and has a hair growth effect of making new hair grow well and a hair restoration effect of making thin and weak hair thick and strong.

Description

복합추출물을 이용한 두피 및 모발의 개선효과 활성을 갖는 조성물{Composition having improvement activity of scalp and hair using compound extract}Composition having improvement activity of scalp and hair using compound extract}

본 발명은 산수국잎추출물, 아르니카몬타나꽃추출물, 회향추출물, 황금추출물, 마트리카리아꽃추출물, 모란뿌리추출물, 살비아추출물, 포트마리골드꽃추출물을 이용하여 모발의 보습효과 및 갈라짐 방지효과, 유연효과, 탈모증과 관련된 피지의 과잉생성을 억제하고 탈모방지효과 및 발모효과, 비듬균에 대한 강력한 항균작용을 가지며 동시에 어린모발을 잘 자라게 해주는 육모효과와 가늘고 힘이 없는 모발을 굵고 튼튼하게 해주는 양모효과 등을 갖는 두피 및 모발의 개선효과 활성을 갖는 조성물에 관한 것이다. The present invention using the hydrangea leaf extract, Arnica montana flower extract, fennel extract, golden extract, Matricaria flower extract, peony root extract, salvia extract, pot marigold flower extract, hair moisturizing effect and cracking prevention effect, supple Effects, inhibits overproduction of sebum associated with alopecia, prevents hair loss and hair growth, has strong antibacterial effects against dandruff, and hair growth to make young hair grow well and wool to make thin and strong hair thick and strong. It relates to a composition having ameliorative activity of the scalp and hair having a.

인체의 모발은 약 10만 내지 15만개 정도이며, 각각의 모발은 서로 다른 주기를 가지며 성장기, 퇴행기, 휴지기를 거쳐 성장, 탈락한다. 이러한 주기는 3 내지 6년에 걸쳐 반복되는데 그 결과 일일 평균 60 내지 100개의 모발이 정상적으로 탈락하게 된다. 일반적으로 탈모증이라 함은 이러한 주기 중에서 성장기의 모발비율이 짧아지고 퇴행기 또는 휴지기의 모발이 많아져 비정상적으로 모발이 탈락하는 숫자가 많아지는 것을 말한다.Human hair is about 100,000 to 150,000 pieces, each hair has a different cycle and grow, drop out through the growth phase, the degenerative phase, the resting phase. This cycle is repeated over three to six years, with the result that on average 60 to 100 hairs fall out normally. In general, alopecia refers to a shortening of hair growth rate in the growth phase and more hair in the degenerative or resting phase due to abnormal hair loss.

또한 두피 이외에도 수염, 겨드랑이, 눈썹, 음모 등에도 볼 수 있으며 심한 경우 온몸에서 탈모가 일어날 수 있다.In addition to the scalp, it can also be seen on the beard, armpits, eyebrows, pubic hair, etc. In severe cases, hair loss may occur all over the body.

탈모의 원인으로는 혈액순환 불량설, 남성호르몬 작용 과잉설, 피지분비 과잉설, 비듬균 및 기타세균 등에 의한 두피 기능저하설, 유전적요인, 노화, 스트레스등이 논의되어 왔었다. 그러나 아직까지 탈모에 관한 명확한 원인은 밝혀지지 않으며, 최근 들어 식생활의 변화, 사회환경 등에 의한 스트레스의 증가 등으로 탈모로 고민하는 인구가 늘어나는 추세이고 그 연령 또한 낮아지고 있으며, 여성의 탈모 인구도 증가하고 있는 추세이다.The causes of hair loss have been discussed such as poor blood circulation, excessive male hormone action, excessive sebum secretion, scalp hypofunction caused by dandruff and other bacteria, genetic factors, aging, stress. However, there is no clear cause for hair loss, and in recent years, more and more people are suffering from hair loss due to changes in diet and stress due to social conditions, and their age is also decreasing. The trend is.

상기의 탈모증의 원인중에서 남성호르몬 과잉분비에 직접적인 관계가 있는 탈모증의 가장 흔한 유형은 남성형 탈모증인데, 이 용어는 안드로겐성 탈모증이라 부르는 것이 좀 더 정확하고 과학적인 명칭이다. 안드로겐성 탈모증이 있는 경우 건강한 모발은 점차로 가늘어지고 짧아지며, 모발이 약해서 쉽게 부서지는 현상이 나타나게 되는데 이러한 현상을 축소화라고 한다.Among the causes of alopecia, the most common type of alopecia, which is directly related to male hormone oversecretion, is masculine alopecia, which is more precise and scientific name called androgenetic alopecia. In the case of androgenetic alopecia, healthy hair becomes thinner and shorter, and the hair is weak and easily broken. This phenomenon is called miniaturization.

축소화가 일어나는 모낭은 결국 가늘고 눈에 잘 보이지 않으며 짧은 솜털로 변해 탈모가 진행되는 것이다.Hair follicles, which shrink, eventually become thin and invisible, turning into short hairs, which leads to hair loss.

이에 따라 최근 남성호르몬활성 억제를 통한 탈모의 예방 및 치료를 위한 많은 연구가 보고되고 있다.Accordingly, many studies have recently been reported for the prevention and treatment of hair loss through inhibition of male hormone activity.

남성호르몬에 대한 탈모의 기전을 간략히 설명하면 다음과 같다.Briefly explain the mechanism of hair loss on male hormones are as follows.

남성호르몬중의 하나인 테스토스테론(testosterone)은 5알파-리덕타아제(5-α-reductase)라는 효소에 의해 활성형 남성호르몬인 디하이드로테스토스테론(dihydrotestosterone)으로 전환되고, 이렇게 활성화된 호르몬이 일정한 수용체와 결합하여 탈모를 일으키는 단백질을 유도하게 되어 탈모를 진행시키게 된다.Testosterone, one of the male hormones, is converted to the active male hormone dihydrotestosterone by an enzyme called 5-alpha-reductase, and the activated hormone is a constant receptor. In combination with and induces a protein that causes hair loss will proceed hair loss.

또한 이와 같은 기전에 의해 피지를 과잉생성하기도 하여 여드름이나 지루성피부염 등을 일으키기도 하며 그 결과로서 두피에서는 염증을 동반한 탈모가 나타나기도 한다.In addition, this mechanism may cause excessive production of sebum, which may cause acne or seborrheic dermatitis, and as a result, scalp may occur with inflammation.

결과적으로 남성형 탈모증은 5알파-리덕타아제의 활성을 억제한다면 남성형 탈모증을 효과적으로 예방 및 치료할 수 있음을 시사한다. As a result, androgenetic alopecia suggests that inhibiting the activity of 5 alpha-reductase can effectively prevent and treat masculine alopecia.

이에 따라 본 출원인은 두피 및 모발의 개선효과 활성성분으로서 여러 한방추출물을 이용하여 연구, 실험한 결과 복합추출물이 모발의 보습효과, 모발의 갈라짐 방지효과, 유연효과, 비듬균에 대한 강력한 항균력을 가지며 동시에 피지의 과잉생성을 억제하여 탈모방지 및 발모효과, 어린모를 잘자라게 해주는 육모효과, 가늘고 힘이 없는 모발을 굵고 튼튼하게 해주는 양모효과 등의 두피 및 모발의 개선효과 활성을 가지고 있음을 발견하였다.Accordingly, the present inventors have studied and experimented with several herbal extracts as active ingredients for improving the scalp and hair, and as a result, the complex extracts have a moisturizing effect of hair, prevention of hair splitting, softening effect, and strong antibacterial activity against dandruff. It has been found to have the effect of improving the scalp and hair by inhibiting the excessive production of sebum, preventing hair loss and hair growth, hair growth effect for growing young hair, and wool effect for thick and strong hair.

따라서, 본 발명의 목적은 두피 및 모발의 개선효과 활성성분으로서 산수국잎추출물, 아르니카몬타나꽃추출물, 회향추출물, 황금추출물, 마트리카리아꽃추출물, 모란뿌리추출물, 살비아추출물, 포트마리골드꽃추출물을 이용하여 두피 및 모발의 개선효과 활성을 갖는 조성물을 제공하는 것이다.Therefore, an object of the present invention is an active ingredient for improving the scalp and hair, as a hydrangea leaf extract, arnica montana flower extract, fennel extract, golden extract, matricaria flower extract, peony root extract, salvia extract, port marigold flower extract By using to provide a composition having the effect of improving the scalp and hair.

본 발명의 두피 및 모발의 개선효과 활성을 갖는 조성물은 유효성분으로서 산수국잎추출물, 아르니카몬타나꽃추출물, 회향추출물, 황금추출물, 마트리카리아꽃추출물, 모란뿌리추출물, 살비아추출물, 포트마리골드꽃추출물이 혼합된 복합추출물을 두피 및 모발용 제형의 총 중량을 기준으로 0.15∼5.00 중량%로 함유하는 것을 특징으로 한다.The composition having the improvement effect of the scalp and hair of the present invention is an active ingredient as a hydrangea leaf extract, arnica montana flower extract, fennel extract, golden extract, matrikaria flower extract, peony root extract, salvia extract, pot marigold flower It is characterized in that the extract contains a mixed extract of 0.15 to 5.00% by weight based on the total weight of the scalp and hair formulation.

또한, 본 발명은 티로시나제 활성촉진제, 침투촉진제, 혈류촉진제, 모포부활제 또는 5α-리덕타제 억제제, 두피영양제, 가려움억제제, 용해보조제, 용제, 계면활성제, 보습제, 점증제, 방부제, 산화방지제, 금속이온봉쇄제, 항염증제, 항미생물제, 계면활성제, 살균제, 착색제, 착향제를 더 포함하는 것을 특징으로 한다.In addition, the present invention is a tyrosinase activator, penetration promoter, blood flow promoter, follicle activator or 5α-reductase inhibitor, scalp nutrient, itch inhibitor, dissolution aid, solvent, surfactant, humectant, thickener, preservative, antioxidant, metal It is characterized in that it further comprises an ion blocking agent, anti-inflammatory agent, antimicrobial agent, surfactant, fungicide, colorant, flavoring agent.

본 발명의 복합추출물을 함유하는 두피 및 모발의 개선효과 활성을 갖는 조성물은 비듬, 가려움방지 및 치료효과, 모발의 보습효과 및 갈라짐 방지효과, 유연효과, 양모효과, 육모효과, 피지의 과잉생성 억제효과, 탈모방지 및 발모효과, 모발성장 촉진효과 등에 대한 활성을 나타내는 효과가 있다.The composition having the improvement effect of the scalp and hair containing the complex extract of the present invention has dandruff, anti-itch and healing effect, hair moisturizing effect and cracking effect, softening effect, wool effect, hair growth effect, sebum overproduction suppression There is an effect of showing the activity on the effect, hair loss prevention and hair growth effect, hair growth promoting effect.

이하, 첨부된 도면을 참조하여 본 발명의 실시예를 설명한다.Hereinafter, with reference to the accompanying drawings will be described an embodiment of the present invention.

본 발명의 두피 및 모발의 개선효과 활성을 갖는 조성물은 산수국잎추출물, 아르니카몬타나꽃추출물, 회향추출물, 황금추출물, 마트리카리아꽃추출물, 모란뿌리추출물, 살비아추출물, 포트마리골드꽃추출물을 포함한다.The composition having the improvement effect of the scalp and hair of the present invention includes a wild hydrangea leaf extract, arnica montana flower extract, fennel extract, golden extract, matricaria flower extract, peony root extract, salvia extract, port marigold flower extract do.

본 발명의 복합추출물 조성물은 산수국잎추출물, 아르니카몬타나꽃추출물, 회향추출물, 황금추출물, 마트리카리아꽃추출물, 모란뿌리추출물, 살비아추출물, 포트마리골드꽃추출물이 동일한 량으로 혼합되는 것이 바람직하다.In the composite extract composition of the present invention, it is preferable that the hydrangea leaf extract, arnica montana flower extract, fennel extract, golden extract, matricaria flower extract, peony root extract, salvia extract and pot marigold flower extract are mixed in the same amount. .

또한, 본 발명에 의한 모발 및 두피의 상태개선이란 두피의 비듬균방지 및 치료효과, 모발의 보습효과, 모발의 갈라짐 방지효과, 유연효과, 양모효과, 육모효과, 탈모방지 및 발모효과, 피지의 과잉생성억제효과, 모발성장 촉진효과 등을 의미한다.In addition, the condition improvement of hair and scalp according to the present invention is to prevent dandruff and treatment effect of the scalp, moisturizing effect of hair, hair splitting effect, softening effect, wool effect, hair growth effect, hair loss prevention and hair growth effect, sebum excess It means production inhibition effect and hair growth promotion effect.

본 명세서에서 "추출물"은 추출 방법, 추출 용매, 추출된 성분 또는 추출물의 형태를 불문하고, 천연물의 성분을 뽑아냄으로써 얻어진 물질을 모두 포함하는 것이며 또한 천연물의 성분을 뽑아내어 얻어진 물질을 추출 후 다른 방법으로 가공 또는 처리하여 얻어질 수 있는 물질을 모두 포함하는 광범위한 개념이다. 예를 들면, 각 성분들의 원물을 세척하는 단계와, 세척된 원물을 물, 알코올 또는 물과 알코올의 혼합물로 이루어진 군에서 선택한 용매와 혼합하여 추출하는 단계와, 혼합물을 살균 여과시켜 여액을 분리하는 단계와; 분리된 여액을 멸균시켜 추출물을 수득하는 단계를 거쳐 생성된다. 이때, 용매와 혼합하는 추출은 약 45도에서 이러한 방법으로 추출한 추출물은 농축 후 동결 건조하여 동결건조물의 형태로서 사용할 수도 있다.As used herein, the term "extract" includes all substances obtained by extracting the components of natural products, regardless of the extraction method, the extraction solvent, the extracted components or the form of the extract, and after extracting the substances obtained by extracting the components of natural products, It is a broad concept that includes all of the materials that can be obtained by processing or processing in a method. For example, washing the raw material of each component, and extracting the washed raw material by mixing with a solvent selected from the group consisting of water, alcohol or a mixture of water and alcohol, and sterilizing and filtering the mixture to separate the filtrate Steps; The separated filtrate is sterilized to yield an extract. In this case, the extraction mixed with the solvent may be used in the form of a freeze-dried by extracting the extract extracted in this way at about 45 degrees after freeze-drying concentrated.

또한, 본 발명의 두피 및 모발의 개선효과 활성을 갖는 조성물은 두피 및 모발의 개선효과 활성을 갖는 보조성분으로서 두피 및 모발의 국부적표면에 직접 적용 될 수 있는 제제라면 제한되지 않는다. 즉, 본 조성물에 함유시킬 수 있는 다른 조성물은 두피 및 모발에 본 발명의 목적의 효과가 확인되며, 또한, 1가지로 본 조성물 중에 배합할 수 있지만 2가지 이상을 배합할 수 있다. 예를 들면, 티로시나제 활성촉진제, 침투촉진제 및 혈류촉진제, 모포부활제, 5α-리덕타제 억제제, 두피영양제, 가려움 억제제 등을 복합추출물 조성물의 함유성분으로서 사용할 수 있다. 그리고 상기 본조성물에 함유되는 성분들의 예시의 내용을 알아본다.In addition, the composition having the improving effect of the scalp and hair of the present invention is not limited as long as it is an agent that can be directly applied to the local surface of the scalp and hair as an auxiliary component having the improving effect of the scalp and hair. That is, the other composition which can be contained in this composition can confirm the effect of the objective of this invention to a scalp and hair, and can also mix | blend two or more types, although it can mix | blend with one type in this composition. For example, tyrosinase activators, penetration promoters and blood flow promoters, follicle inactivators, 5α-reductase inhibitors, scalp nutrients, anti-itch agents, and the like can be used as components of the composite extract composition. And the contents of the examples of the components contained in the composition.

티로시나제 활성촉진제는 상백피추출물, 녹차추출물 등을 사용할 수 있다. 티로시나제 활성촉진제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.2중량비로 첨가되는 것이 바람직하다.Tyrosinase activator may be an extract of green tea, green tea extract, and the like. The tyrosinase activator is preferably added in an amount of 0.1 to 0.2% by weight based on the total weight of the composite extract composition.

침투촉진제 및 혈류촉진제는 창포추출물, 당귀추출물, 위치하젤추출물, 연명초추출물, 천궁추출물, 카모마일추출물, 홍삼추출물, 당약추출물 등을 사용할 수 있다. 침투촉진제 및 혈류촉진제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.5중량비로 첨가되는 것이 바람직하다.Penetrant accelerators and blood flow promoters may be used iris extracts, Angelica extracts, witch hazel extracts, lichen herb extracts, cheongung extracts, chamomile extracts, red ginseng extracts, sugar extracts. Penetration accelerator and blood flow promoter is preferably added in a 0.1 to 0.5 weight ratio based on the total weight of the composite extract composition.

모포부활제는 지황추출물, 홍삼추출물, 산초추출물, 당약추출물 등을 사용할 수 있다. 모포부활제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.5중량비로 첨가되는 것이 바람직하다.The follicle rejuvenating agent may be a sulfur extract, red ginseng extract, acid extract, sugar extract, and the like. It is preferable that a blanket activator is added in 0.1 to 0.5 weight ratio with respect to the total weight of the composite extract composition.

5α-리덕타제 억제제는 감초추출물, 금잔화추출물, 알로에추출물, 고삼추출물, 천궁추출물, 지황추출물, 당귀추출물 등을 사용할 수 있다. 5α-리덕타제 억제제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.5중량비로 첨가되는 것이 바람직하다.As a 5α-reductase inhibitor, licorice extract, marigold extract, aloe extract, red ginseng extract, cheongung extract, yolk extract, sugar extract, and the like can be used. The 5α-reductase inhibitor is preferably added at a ratio of 0.1 to 0.5% by weight based on the total weight of the composite extract composition.

두피영양제는 철분, 칼슘, 망간, 필수아미노산, 염산 피리독신, 비오틴, 비타민B1, 비타민B2, 비타민B6, 비타민D 및 엽산으로 이루어진 1가지 이상되는 비타민 또는 비타민 전구체, 멘톨 디엘-판테놀, 폴리쿼터늄-7, 트리세틸모늄클로라이드, 디메치콘/이소라우레스-6, 복합추출물(효모, 금, 프로폴리스, 인삼, 마치현, 정향, 하수오), 세틸트리메칠암모늄클로라이드, 세테아릴알코올, 케라틴아미노산, 사이클로펜타실록산/디메치콘, 디메치콘/이소라우레스-6 이외 각종 미네랄 등을 사용할 수 있다. 두피영양제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.3중량비로 첨가되는 것이 바람직하다.Scalp nutrients include one or more vitamins or vitamin precursors consisting of iron, calcium, manganese, essential amino acids, pyridoxine hydrochloride, biotin, vitamin B1, vitamin B2, vitamin B6, vitamin D, and folic acid, menthol di-panthenol, polyquaternium- 7, tricetylmonium chloride, dimethicone / isolaures-6, complex extract (yeast, gold, propolis, ginseng, machi, clove, sewage), cetyltrimethylammonium chloride, cetearyl alcohol, keratinamino acid, Various minerals other than cyclopentasiloxane / dimethicone, dimethicone / isolaureth-6, etc. can be used. The scalp nutrient is preferably added in a weight ratio of 0.1 to 0.3 based on the total weight of the composite extract composition.

가려움억제제는 컴푸리추출물, 고삼추출물, 범부채추출물, 페파민트 및 이들의 혼합물 등을 사용할 수 있다. 가려움억제제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.2중량비로 첨가되는 것이 바람직하다.Itching inhibitors can be used extracts, gourd extract, panchae extract, peppermint and mixtures thereof. Itch suppressant is preferably added in a 0.1 to 0.2 weight ratio based on the total weight of the composite extract composition.

또한, 본 발명은 외용조성물(모발조성물)에 배합될 수 있는 일반적인 기제 성분이나 약효성분을 구체적인 조성물의 제형이나 형태에 따라 이의 제형이나 형태에서 원하는 효과를 손상하지 않는 한, 품질을 유지하기 위해 사용되는 것들을 배합할 수 있다. 구체적으로는 용해보조제, 용제, 계면활성제, 보습제, 점증제, 방부제, 산화방지제, 금속이온봉쇄제, 항염증제, 항미생물제, 살균제, 착색제, 착향제 등을 목적으로 하는 제형이나 형태에 따라 적절하게 선택하여 배합할 수 있다.In addition, the present invention is used to maintain the quality as long as the general base ingredient or the active ingredient that can be blended in the external composition (hair composition) does not impair the desired effect in the formulation or form of the specific composition according to the formulation or form of the specific composition. Can be combined. Specifically, the solubilizer, solvent, surfactant, moisturizer, thickener, preservative, antioxidant, metal ion sequestrant, anti-inflammatory agent, antimicrobial agent, bactericide, colorant, flavoring agent, etc. are appropriately selected according to the formulation or form for the purpose. Can be blended.

용해보조제로서는 이소프로필 미리스테이트, 포리에틸렌 글리콜, 중쇄 지방산 트리글리세리드, 탄화수소, 글리콜류 등을 사용할 수 있다. 용해보조제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.2중량비로 첨가되는 것이 바람직하다.As the dissolution aid, isopropyl myristate, polyethylene glycol, medium chain fatty acid triglycerides, hydrocarbons, glycols and the like can be used. Dissolving aid is preferably added in a 0.1 to 0.2 weight ratio based on the total weight of the composite extract composition.

용제로서는 에탄올, 정제수, 트윈20, 사이클로메치콘, 미네랄오일, 디메치콘 등을 사용할 수 있다. 용제는 복합추출물 조성물의 총중량에 대하여 0.5 내지 0.8중량비로 첨가되는 것이 바람직하다.As the solvent, ethanol, purified water, Tween 20, cyclomethicone, mineral oil, dimethicone and the like can be used. The solvent is preferably added in a 0.5 to 0.8 weight ratio based on the total weight of the composite extract composition.

계면활성제는 음이온계 계면활성제, 비이온성 계면활성제, 양이온성 계면활성제의 어느 하나를 사용할 수 있다. 계면활성제는 복합추출물 조성물의 총중량에 대하여 1 내지 50중량비로 첨가되는 것이 바람직하다.Surfactant can use any of anionic surfactant, nonionic surfactant, and cationic surfactant. The surfactant is preferably added in a ratio of 1 to 50% by weight based on the total weight of the composite extract composition.

보습제로서는 예를 들면 글리세린, 프로필렌글리콜, 1, 3-부틸렌글리콜, 디프로필렌글리콜, 소르비톨 등을 사용할 수 있다. 보습제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.5중량비로 첨가되는 것이 바람직하다.As the moisturizing agent, for example, glycerin, propylene glycol, 1, 3-butylene glycol, dipropylene glycol, sorbitol and the like can be used. Moisturizing agent is preferably added in a 0.1 to 0.5 weight ratio based on the total weight of the composite extract composition.

점증제로서는 예를 들면 메틸셀룰로스, 하이드록시에틸셀룰로스, 카라기난, 카르복시메틸셀룰로스, 폴리쿼터늄-10, 염화나트륨, 하이드록시메틸셀룰로스 등이 사용되고, pH 조정제에는 구연산, 수산화나트륨, 트리에탄올아민, 구연산나트륨, 인산, 인산나트륨, 젖산 등을 사용할 수 있다. 점증제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.5중량비로 첨가되는 것이 바람직하다.As the thickener, for example, methyl cellulose, hydroxyethyl cellulose, carrageenan, carboxymethyl cellulose, polyquaternium-10, sodium chloride, hydroxymethyl cellulose and the like are used, and citric acid, sodium hydroxide, triethanolamine, sodium citrate, Phosphoric acid, sodium phosphate, lactic acid and the like can be used. The thickener is preferably added in a 0.1 to 0.5 weight ratio based on the total weight of the composite extract composition.

방부제로서는 예를 들면 벤조산, 파라옥시안식향산에스테르, 메칠클로로이소치아졸리논의 혼합물, 페녹시에탄올, 디엠디엠 히단토인 등을 사용할 수 있다. 방부제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.3중량비로 첨가되는 것이 바람직하다.As the preservative, for example, a mixture of benzoic acid, paraoxybenzoic acid ester, methylchloroisothiazolinone, phenoxyethanol, DMDM hydantoin and the like can be used. Preservatives are preferably added in a 0.1 to 0.3 weight ratio based on the total weight of the composite extract composition.

산화방지제로서는 예를 들면 디부틸히드록시톨루엔, 아스코르빈산 등을 사용할 수 있다. 산화방지제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.2중량비로 첨가되는 것이 바람직하다.As the antioxidant, for example, dibutyl hydroxytoluene, ascorbic acid and the like can be used. Antioxidant is preferably added in a 0.1 to 0.2 weight ratio based on the total weight of the composite extract composition.

금속이온봉쇄제로서는 예를 들면 에칠렌디아민테트라초산디나트륨, 에칠렌디아민테트라초산테트라나트륨 등을 사용할 수 있다. 금속이온봉쇄제는 복합추출물 조성물의 총중량에 대하여 0.01 내지 0.1중량비로 첨가되는 것이 바람직하다.As the metal ion blocking agent, for example, ethylenediaminetetraacetate acetate, ethylenediaminetetraacetate tetrasodium and the like can be used. The metal ion sequestrant is preferably added in an amount of 0.01 to 0.1 weight based on the total weight of the composite extract composition.

항염증제로서는 예를 들면 글리시리진산모노암모늄, 글리시리진산디칼륨, 스테아릴글리시리지네이트, 카모마일, 알파 비사보롤, 알란토인 및 이들의 혼합물 등으로 구성되는 것으로부터 선택된 것을 사용할 수 있다. 항염증제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.2중량비로 첨가되는 것이 바람직하다.As the anti-inflammatory agent, for example, those selected from monoammonium glycyrrhinate, dipotassium glycyrizine, stearyl glycyrizinate, chamomile, alpha bisabolol, allantoin, mixtures thereof, and the like can be used. Anti-inflammatory agent is preferably added in a 0.1 to 0.2 weight ratio based on the total weight of the composite extract composition.

항미생물제로서는 예를 들면 페녹시에탄올, 클로르헥시딘, 클로르헥시딘 글루코네이트, 피록톤올아민, 케토코나졸 아르니카추출물, 요도프로피닐부틸카바메이트, 벤잘코늄클로라이드, 벤젠토늄클로라이드, 벤조산 및 그의 염, 벤질알코올 라벤다, 로즈마리, 살리실산, 트리클로카르반, 아연피리치온현탁액 및 그들의 혼합물 등을 사용할 수 있다. 항미생물제는 복합추출물 조성물의 총중량에 대하여 0.1 내지 0.2중량비로 첨가되는 것이 바람직하다.As antimicrobial agents, for example, phenoxyethanol, chlorhexidine, chlorhexidine gluconate, pyroxtonolamine, ketoconazole arnica extract, iodopropynylbutylcarbamate, benzalkonium chloride, benzenetonium chloride, benzoic acid and its salts, benzyl alcohol lavender, rosemary, Salicylic acid, triclocarban, zinc pyrithione suspensions, mixtures thereof and the like can be used. The antimicrobial agent is preferably added in a 0.1 to 0.2 weight ratio based on the total weight of the composite extract composition.

살균제로서는 예를 들면 클로르헥시딘 글루코네이트, 4급 암모늄염, 피록톤올아민, 아연피리치온현탁액, 요도프로피닐 부틸카바메이트, 살리실산 등을 사용할 수 있다. 살균제는 복합추출물 조성물의 총중량에 대하여 0.01 내지 0.1중량비로 첨가되는 것이 바람직하다.As the bactericide, for example, chlorhexidine gluconate, quaternary ammonium salt, pyrotonolamine, zinc pyrithione suspension, iodopropynyl butyl carbamate, salicylic acid and the like can be used. The fungicide is preferably added in an amount of 0.01 to 0.1 weight based on the total weight of the composite extract composition.

본 발명의 복합추출물 조성물은 헤어토닉, 헤어팩, 삼푸, 삼푸와 린스혼합형 등의 통상 두피 및 모발에 적용시킬 수 있는 모든 제형의 형태를 선택되는 제품 형태의 하나이며, 본 조성물은 대체적으로 두피나 모발에 직접 도포 하거나 살포하는 등의 모발 또는 경피 투여에 의해 사용된다. 그리고 본 조성물의 사용량은 연령, 병변의 정도 등의 개인차이나 제형, 형태에 따라 적절하게 결정되어야 한다. 이와 같이 본 조성물은 각종 모발처리제로서 의약품, 의약외품 또는 화장품 등의 다양한 분야에서 바람직하게 이용할 수 있다. 본 발명의 복합추출물 조성물은 두피 및 모발용 제형의 총 중량의 0.15∼5.00 % 범위 내에서 조성물 형태에 따라 다르게 적용된다.The complex extract composition of the present invention is one of the product form selected from the form of all formulations that can be applied to the normal scalp and hair, such as hair tonic, hair pack, shampoo, shampoo and rinse mixture, the composition is generally scalp or hair Used by hair or transdermal administration, such as direct application or spraying on. In addition, the amount of the composition to be used should be appropriately determined according to individual differences, dosage forms, and forms such as age and degree of lesion. As described above, the present composition can be suitably used in various fields such as pharmaceuticals, quasi-drugs, or cosmetics as various hair treatment agents. The composite extract composition of the present invention is applied differently depending on the composition form within the range of 0.15 to 5.00% of the total weight of the scalp and hair formulation.

이하, 본 발명의 복합추출물을 이용한 두피 및 모발의 개선효과 활성을 갖는 조성물 을 조성물에 대한 바람직한 실시예를 상세하게 설명한다.Hereinafter, a preferred embodiment of the composition having a composition having the effect of improving the scalp and hair using the complex extract of the present invention will be described in detail.

그러나 이들에 의해 본 발명의 기술적 범위가 한정되는 것은 아니며, 또한 이들 실시예의 제제예 등에서의 배합량은 특별히 단정하지 않는 한, 이의 성분이 배합되는 시스템 전체에 대한 중량% 이다.However, the technical range of this invention is not limited by these, and the compounding quantity in the preparation example of these Examples, etc. is the weight% with respect to the whole system to which the component is mix | blended unless it is specifically determined.

<복합추출물 혼합물의 제조>Preparation of Complex Extract Mixture

산수국잎, 아르니카몬타나꽃, 회향, 황금, 마트리카리아꽃, 모란뿌리, 살비아, 포트마리골드꽃의 각 원물을 동량 총 1kg을 정제수로 세척하였다. 그리고, 세척된 원물을 70% 에탄올 수용액으로 24시간씩 3회 환류 추출하고 냉침한 후, 와트만(Whatman) #5 여과지로 여과하여 복합추출물을 제조하였다.A total of 1 kg of each of the raw materials of the hydrangea leaf, arnica montana flower, fennel, golden, matricaria flower, peony root, salvia, and port marigold flower were washed with purified water. Then, the washed raw material was extracted by refluxing three times for 24 hours with a 70% ethanol aqueous solution, and then cooled, and then mixed with Whatman # 5 filter paper to prepare a composite extract.

<복합추출물 조성물 함유하는 헤어토닉의 제조><Production of Hair Tonic Containing Complex Extract Composition>

표 1에 나타낸 3가지 제형으로 각각의 원료를 계량하여 Disper Mixer 500 rpm 으로 5분간 교반한 후 여과하여 실시예1,2,3의 헤어토닉을 제조하였다. 또한, 복합추출물 조성물이 첨가되지 않은 제형으로 비교예1,2,3의 헤어토닉을 제조하였다.Each of the raw materials were weighed by three formulations shown in Table 1, stirred at 500 rpm for 5 minutes, and filtered to prepare hair tonics of Examples 1, 2, and 3. In addition, the hair tonic of Comparative Examples 1, 2, and 3 was prepared in the formulation without the composite extract composition.


배합목적

Purpose of Mixing

원료명

Raw material name
분 량 (g)Quantity (g)
실시예1Example 1 실시예2Example 2 실시예3Example 3 비교예1Comparative Example 1 비교예2Comparative Example 2 비교예3Comparative Example 3 용제solvent 정제수Purified water 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 보습제Moisturizer 1, 3부틸렌글리콜1,3-butylene glycol 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 두피영양제Scalp Nutritional Supplements 비오틴Biotin 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 금속이온봉쇄제Metal Ion Blocker 에칠렌디아민테트라초산디나트륨Ethylenediaminetetradiacetic acid sodium 0.030.03 0.030.03 0.030.03 0.030.03 0.030.03 0.030.03 항염증제Anti-inflammatory 알란토인Allantoin 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 용제solvent 에탄올ethanol 30.0030.00 30.0030.00 30.0030.00 30.0030.00 30.0030.00 30.0030.00 두피영양제Scalp Nutritional Supplements 멘톨menthol 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 착향제Flavor 향료Spices 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 방부제antiseptic 디엠디엠히단토인DMH Hidantoin 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 복합추출물Complex extract 1.001.00 2.002.00 5.005.00 pH조정제pH adjuster 구연산Citric acid 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 살균제disinfectant 살리실산Salicylic acid 0.100.10 0.200.20 0.300.30 0.100.10 0.100.10 0.100.10 용제solvent 트윈20Twin 20 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 방부제antiseptic 파라옥시안식향산메칠Paraoxybenzoic Acid Methyl 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 항염증제Anti-inflammatory 글리시리진산디칼륨Dipotassium glycyrrhinate 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 가려움억제제Itching Inhibitor 페파민트Peppermint 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10

<복합추출물 조성물을 함유하는 삼푸의 제조><Production of Shampoo Containing Complex Extract Composition>

표 2에 나타낸 3가지 제형으로 각각의 원료 중 향료, 정제수를 제외한 원료들을 혼합한 후 80℃ 까지 가열하여 교반하면서 완전히 용해시키고, 냉각하면서 40℃에서 향료, 색소와 정제수를 첨가하여 30℃에서 냉각을 종료하여 실시예4,5,6의 삼푸를 제조하였다. 또한, 복합추출물 조성물이 첨가되지 않은 제형으로 비교예4,5,6의 삼푸를 제조하였다.The three formulations shown in Table 2 were mixed with each other except the fragrance and purified water, and then heated to 80 ° C. to complete dissolution while stirring. The shampoo of Example 4, 5, 6 was prepared by terminating the same. In addition, the extract of Comparative Example 4, 5, 6 was prepared in a formulation without the composite extract composition.


배합목적

Purpose of Mixing

원료명

Raw material name
분량 (g)Quantity (g)
실시예4Example 4 실시예5Example 5 실시예6Example 6 비교예4Comparative Example 4 비교예5Comparative Example 5 비교예6Comparative Example 6 용제solvent 정제수Purified water 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 금속이온봉쇄제Metal Ion Blocker 에칠렌디아민테트라초산디나트륨Ethylenediaminetetradiacetic acid sodium 0.010.01 0.010.01 0.010.01 0.010.01 0.010.01 0.010.01 두피영양제Scalp Nutritional Supplements 디엘-판테놀Diel-Pantenol 0.200.20 0.200.20 0.200.20 0.200.20 0.200.20 0.200.20 보습제Moisturizer 프로필렌글리콜Propylene glycol 0.500.50 0.500.50 0.500.50 0.500.50 0.500.50 0.500.50 점증제Thickener 폴리쿼터늄-10Polyquaternium-10 0.350.35 0.350.35 0.350.35 0.350.35 0.350.35 0.350.35 계면활성제Surfactants 암모늄 라우레스-3 설페이트Ammonium Laureth-3 Sulfate 15.0015.00 15.0015.00 15.0015.00 15.0015.00 15.0015.00 15.0015.00 계면활성제Surfactants 소듐 라우레스-3 설페이트Sodium Laureth-3 Sulfate 40.0040.00 40.0040.00 40.0040.00 40.0040.00 40.0040.00 40.0040.00 계면활성제Surfactants 코카미도 프로필베타인Kokamido Profile 8.008.00 8.008.00 8.008.00 8.008.00 8.008.00 8.008.00 두피영양제Scalp Nutritional Supplements 폴리쿼터늄-7Polyquaternium-7 2.502.50 2.502.50 2.502.50 2.502.50 2.502.50 2.502.50 pH 조정제pH regulator 인산나트륨Sodium phosphate 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 계면활성제Surfactants 글리콜 디스테아레이트Glycol distearate 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 계면활성제Surfactants 코카마이드 엠이에이Cocamide MEI 1.801.80 1.801.80 1.801.80 1.801.80 1.801.80 1.801.80 계면활성제Surfactants 포타슘 코코일 글루타메이트Potassium cocoyl glutamate 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 점증제Thickener 염화나트륨Sodium chloride 0.800.80 0.800.80 0.800.80 0.800.80 0.800.80 0.800.80 두피영양제Scalp Nutritional Supplements 트리세틸모늄클로라이드Tricetylmonium chloride 0.500.50 0.500.50 0.500.50 0.500.50 0.500.50 0.500.50 살균제disinfectant 살리실산Salicylic acid 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 살균제disinfectant 요도프로피닐부틸카바메이트Urethral propynylbutyl carbamate 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 두피영양제Scalp Nutritional Supplements 디메치콘/이소라우레스-6Dimethicone / isolauresu-6 3.203.20 3.203.20 3.203.20 3.203.20 3.203.20 3.203.20 방부제antiseptic 메칠클로로이소치아졸리논/
메칠클로로치아졸리논
Methylchloroisothiazolinone /
Methylchlorothiazolinone
0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05
복합추출물Complex extract 0.300.30 1.001.00 2.002.00 벌킹제Bulking agent 벤토나이트Bentonite 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 계면활성제Surfactants 포타슘코코일글리시네이트Potassium Coyl Glycinate 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 착색제coloring agent 색소Pigment 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 착향제Flavor 향료Spices 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity

〈복합추출물 조성물을 함유하는 헤어트리트먼트의 제조><Production of Hair Treatment Containing Complex Extract Composition>

표 3 에 나타낸 3가지 각각의 원료중 원료 1∼5번을 계량하여 80℃ 까지 가온한다(1). 그다음에 원료 6∼13번을 계량하여 80℃ 까지 가온한다(2). (1)(2)의 온도 및 용해상태를 확인한후 (1)에 (2)를 투입하여 유화를 실시한다. Homo Mixer 2500 rpm 및 Disper Mixer 25 rpm 으로 3분간 교반한후, 냉각을 시작한다. 40℃에서 원료 14∼20까지를 투입하여 교반 및 냉각을 하여 30℃에서 종료하여 실시예7,8,9의 헤어트리트먼트를 제조하였다. 또한, 복합추출물 조성물이 첨가되지 않은 제형으로 비교예7,8,9의 헤어트리트먼트를 제조하였다.In each of the three raw materials shown in Table 3, raw materials 1 to 5 were weighed and heated to 80 ° C (1). Thereafter, raw materials 6 to 13 were weighed and heated to 80 ° C (2). After confirming the temperature and the dissolved state of (1) (2), (2) is added to (1) to emulsify. After stirring for 3 minutes at Homo Mixer 2500 rpm and 25 rpm Disper Mixer, cooling starts. The raw materials 14-20 were added at 40 degreeC, and it stirred and cooled, and terminated at 30 degreeC, and the hair treatment of Examples 7, 8, and 9 was produced. In addition, the hair extract of Comparative Example 7, 8, 9 was prepared in a formulation in which the composite extract composition was not added.


배합목적

Purpose of Mixing

원료명

Raw material name
분량 (g)Quantity (g)
실시예7Example 7 실시예8Example 8 실시예9Example 9 비교예7Comparative Example 7 비교예8Comparative Example 8 비교예9Comparative Example 9 용제solvent 정제수Purified water 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 점증제Thickener 구아르 하이드록시프로필 트리모늄클로라이드Guar hydroxypropyl trimonium chloride 0.500.50 0.500.50 0.500.50 0.500.50 0.500.50 0.500.50 보습제Moisturizer 프로필렌글리콜Propylene glycol 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 두피영양제Scalp Nutritional Supplements 세틸트리메칠암모늄클로라이드Cetyltrimethylammonium chloride 1.001.00 1.001.00 1.001.00 1.001.00 1.001.00 1.001.00 방부제antiseptic 메칠파라벤Methylparaben 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 계면활성제Surfactants 스테아르트리모늄 클로라이드Steartrimonium chloride 4.004.00 4.004.00 4.004.00 4.004.00 4.004.00 4.004.00 계면활성제Surfactants 글리세릴 스테아레이트Glyceryl Stearate 2.502.50 2.502.50 2.502.50 2.502.50 2.502.50 2.502.50 두피영양제Scalp Nutritional Supplements 세테아릴알코올Cetearyl Alcohol 6.006.00 6.006.00 6.006.00 6.006.00 6.006.00 6.006.00 방부제antiseptic 프로필 파라벤Profile paraben 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 용제solvent 사이클로메치콘Cyclomethicone 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 용제solvent 미네랄오일Mineral oil 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 두피영양제Scalp Nutritional Supplements 사이클로펜타실록산/디메치콘Cyclopentasiloxane / dimethicone 3.003.00 3.003.00 3.003.00 3.003.00 3.003.00 3.003.00 용제solvent 디메치콘Dimethicone 0.500.50 0.500.50 0.500.50 0.500.50 0.500.50 0.500.50 착색제coloring agent 색소Pigment 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 두피영양제Scalp Nutritional Supplements 디메치콘/이소라우레스-6Dimethicone / isolauresu-6 3, 003, 00 3, 003, 00 3, 003, 00 3, 003, 00 3, 003, 00 3, 003, 00 두피영양제Scalp Nutritional Supplements 복합추출물Complex extract 015015 1.501.50 3.003.00 두피영양제Scalp Nutritional Supplements 케라틴아미노산Keratinamino acids 0.200.20 0.200.20 0.200.20 0.200.20 0.200.20 0.200.20 살균제disinfectant 피록톤올아민Pyrotonolamine 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 용제solvent 에탄올ethanol 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 복합추출물Complex extract 1.001.00 3.003.00 5.005.00 착향제Flavor 향료Spices 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity

<복합추출물을 함유하는 조성물의 두피 및 모발의 개선효과활성을 갖는 실험평가><Experimental evaluation with improving effect activity of scalp and hair of composition containing complex extract>

실험예1 : 복합추출물을 함유하는 제형의 탈모방지, 발모, 양모, 육모, 피지의 과잉생성 억제효과에 대한 실험평가Experimental Example 1: Experimental evaluation on the effect of inhibiting hair loss, hair growth, wool, hair growth, sebum overproduction of the formulation containing the complex extract

〈임상실험평가대상〉〈Clinical Experiment Evaluation Subject〉

표 4과 같이 분류된 모델그룹을 임상실험평가대상으로 선정하였다.Model groups classified as shown in Table 4 were selected for clinical trial evaluation.

모델그룹Model Group 모발의 상태Hair condition 제1그룹1st group 탈모현상이 육안평가시 50%이상 진행중이며, 피지가 과잉생성되는 20대부터 50대성인 남성12명  Hair loss is more than 50% in visual evaluation and 12 men in their 20s to 50s who are overly sebum produced. 제2그룹2nd group 탈모현상이 육안평가시 50%이상 진행중이며, 피지가 과잉생성되는 20대부터 50대성인 남성 10명 Hair loss is more than 50% in visual evaluation, and 10 men in their 20s to 50s have excessive sebum production. 제3그룹3rd group 탈모는 아니나 육안평가시 머리카락이 가는 것이 많고, 많아 빠지며, 피지가 과잉생성되는 20대부터 50대까지 남성 14명과 여성 22명  Although not hair loss, 14 men and 22 women in their 20's to 50's have a lot of hairs, and they fall out when they are visually evaluated. 제4그룹4th group 육안평가시 건강한 모발로 보이지만 평상시 머리카락이 많이 빠지는 18세부터 50대까지 남성 20명과 여성 30명  20 males and 30 females from 18 to 50 years of age who look healthy hair but usually lose a lot of hair.

<임상실험평가결과>Clinical Trial Results

표 4의 임상실험평가 모델그룹을 대상으로 실시예3의 헤어토닉, 실시예6의 샴푸, 실시예8의 트리트먼트를 1일 1∼3회 이상 평균 4 개월 동안 사용하여 탈모방지, 발모, 양모, 육모, 피지의 과잉생성 억제효과에 대한 실험평가를 실시하여 그 결과를 표 5에 나타내었다.(임상실험평가에서의 점수는 각 그룹에 속한 모델의 개선된 효과상태를 상 : 8∼10점, 중 : 5∼7점, 하 : 0∼4점으로 하고 이것을 각 모델그룹의 점수를 평균화 한 결과를 조성물에 대한 효과로 나타내었다.)The hair tonic of Example 3, the shampoo of Example 6, and the treatment of Example 8 were used at least once or three times a day for an average of 4 months in the clinical trial evaluation model group of Table 4 to prevent hair loss, hair growth, and wool. The results of the experimental evaluation on the inhibitory effects of overgrowth of hair, hair growth and sebum are shown in Table 5. (The scores in the clinical trial evaluation show the improved effects of the models belonging to each group: 8 to 10 points. The results of averaging the scores of each model group were expressed as the effect on the composition.

모델그룹Model Group 탈모방지효과Hair loss prevention effect 발모효과Hair growth effect 육모효과Hair growth effect 양모효과Wool effect 피지과잉생성억제효과Sebum overproduction inhibitory effect 제1그룹1st group 7.8점7.8 points 2.82.8 5.45.4 5.85.8 8.48.4 제2그룹2nd group 8.3점8.3 points 3.93.9 6.16.1 5.75.7 8.48.4 제3그룹3rd group 9.7점9.7 points 3.63.6 5.65.6 5.75.7 9.09.0 제4그룹4th group 8.6점8.6 points -- -- -- --

표 5에 나타난 바와 같으며, 실험결과 중 피부의상태도 특이한 피부자극 소견이 발견되지 않으면서 두피 및 모발의 개선효과활성이 우수한 것으로 평가되었다.As shown in Table 5, it was evaluated that the skin condition was excellent in the improvement effect activity of the scalp and hair without finding any unusual skin irritation findings.

또한, 모발의 탈락주기가 보통사람인 경우 일일 평균 60∼100여 개는 정상이지만 탈모가 진행중인 사람에게서 일일 탈락의 숫자가 90%∼40%로 탈락속도가 저하하는 것으로 나타나 표 8 과 같이 탈모방지효과가 매우 우수한 것으로 평가됐다.In addition, in the case of the average hair dropping cycle, the average daily dropping rate is about 60 to 100, but the dropout rate decreases to 90% to 40% in the number of dropouts in progress. Was rated very excellent.

그리고, 표 5의 결과에서 발모효과의 점수가 저조한 것은 단지 실험기간중에 나타난 평가의 결과이고, 조성물을 지속적으로 사용하는 모델에게 있어 효과면에 대한 점수는 계속하여 증가되고 있다.In addition, the low score of the hair growth effect in the results of Table 5 is only a result of the evaluation during the experimental period, the score for the effect surface continues to increase for the model using the composition continuously.

실험예2 : 복합추출물의 비듬균에 대한 항균력 효과실험Experimental Example 2: Antibacterial effect test on the dandruff bacteria of the complex extract

본 발명의 복합추출물의 비듬균에 대한 항균력실험은 액체배지에서 배양시킨 지성비듬균(pityrosporum ovale)에 0.5% 농도의 복합추출물을 가하거나, 건성비듬균에 0.3% 농도의 복합추출물을 가하여 혐기성배양조에서 배양한 후 각 비듬균의 발육을 억제하는 최소억제 농도(MIC)를 확인하였다.The antimicrobial activity test for the dandruff bacteria of the complex extract of the present invention was added to 0.5% concentration of the composite extract to pistrosporum ovale cultured in a liquid medium, or 0.3% concentration of the composite extract to dry dandruff cultured in anaerobic culture tank After that, the minimum inhibitory concentration (MIC) that inhibits the growth of each dandruff was confirmed.

그 결과 아세틸살리산의 각 비듬균에 대한 최소억제농도 범위는 지성비듬균 10∼100 ppm, 건성비듬균 7∼100 ppm 으로 평가되었다.As a result, the range of minimum inhibitory concentration of acetylsalicylic acid for each dandruff was estimated to be 10-100 ppm of oily dandruff and 7-100 ppm of dry dandruff.

실험예3 : 복합추출물을 함유하는 제형의 비듬균에 대한 항균력 효과실험Experimental Example 3: Antibacterial effect test on dandruff bacteria of the formulation containing the complex extract

〈임상실험평가대상〉〈Clinical Experiment Evaluation Subject〉

표 6과 같이 분류된 모델그룹을 임상실험평가대상으로 선정하였다.Model groups classified as shown in Table 6 were selected for clinical trial evaluation.

모델그룹Model Group 모 발 의 상 태Hair condition 제1그룹1st group 탈모현상이 육안평가시 50%이상 진행중이며 지성비듬균이 있는 20대부터 60대성인 남성 15명Hair loss is more than 50% in visual evaluation and 15 males in their 20s to 60s with oily dandruff 제2그룹2nd group 탈모현상이 육안평가시 10%이상 진행중이며 건성비듬균이 있는 20대부터 60대성인 남성 15명Hair loss is more than 10% in visual evaluation and 15 men in their 20s to 60s with dry dandruff 제3그룹3rd group 두피에 지루성피부염을 동반한 지성비듬균이 있는 10대부터 50대까지 남성 15명 과 여성 20명15 males and 20 females from 10s to 50s with oily dandruff with seborrheic dermatitis 제4그룹4th group 육안평가시 건강한모발로 보이면서 기타비듬균이 있는 10대부터 60대까지 남성20명 과 여성 20명20 males and 20 females from teenagers to 60s with other dandruff bacteria appearing as healthy hair when visual evaluation

〈임상실험평가결과〉<Clinical Trial Evaluation Results>

표 6의 모델그룹을 대상으로 실시예3의 헤어토닉, 실시예6의 샴푸, 실시예8의 트리트먼트를 지속적으로 전달하면서 7일에 1회 정도, 평균 3개월 동안 사용하고 각 그룹에 대한 비듬균에 대한 항균성 효과를 확인하여 표 7에 나타내었다(임상실험평가에서의 점수는 각 그룹에 속한 모델의 개선된 효과상태를 상 : 8∼10점, 중 : 5∼7점, 하 : 0∼4점으로 나누고 이것을 각 모델그룹의 점수를 평균화 한 결과를 조성물에 대한 효과로 나타냈다). The hair tonic of Example 3, the shampoo of Example 6, and the treatment of Example 8 were continuously applied to the model group of Table 6, and used once every 7 days, for an average of 3 months. Table 7 shows the antimicrobial effect on the results of the clinical trials. Dividing by points and averaging the scores of each model group as the effect on the composition).

모 델 그 룹Model group 제1그룹1st group 제2그룹2nd group 제3그룹3rd group 제4그룹4th group 비듬균에 대한 항균력 효과Antimicrobial Effects on Dandruff 9.3점9.3 points 8.8점8.8 points 3.5점3.5 points 5.5점5.5 points

표 7과 결과와 같이 본 발명의 복합추출물이 함유된 헤어토닉, 샴푸, 트리트먼트를 사용한 임상실험 과정 중 피부의 상태도 특이한 피부자극소견이 발견되지 않으면서 비듬균에 대한 항균력이 우수한 것으로 평가되었다.As shown in Table 7 and results, it was evaluated that the anti-microbial activity against dandruff was excellent without any unusual skin irritation findings during the clinical trial process using the hair tonic, shampoo and treatment containing the complex extract of the present invention.

또한, 본 조성물의 비듬균에 대한 항균력 실험에 있어서, 복합추출물의 함량은 제형을 유지할 수 있는 범위에서 사용농도 제한은 0.15∼5.00%로 제한을 두며, 특히 지성비듬균과 건성비듬균 및 기타 비듬균에 대한 항균력효과가 우수한 것으로 평가되었다.In addition, in the antibacterial activity test against dandruff bacteria of the present composition, the limit of the concentration of the complex extract in the range that can maintain the formulation is limited to 0.15 ~ 5.00%, in particular antibacterial activity against oily and dry dandruff and other dandruff bacteria The effect was evaluated to be excellent.

또한, 장기간에 걸쳐 사용하여도 피부발작 등의 부작용이 나타나지 않는 비듬균에 대한 항균력 효과가 우수한 것으로 사료된다.In addition, the antimicrobial effect against dandruff which does not show side effects such as skin attack is considered to be excellent even after long-term use.

실험예4 : 복합추출물을 함유하는 제형의 유연, 보습, 모발의 갈라짐 방지 효과에 대한 실험평가.Experimental Example 4: Experimental evaluation of the softening, moisturizing, and hair splitting effect of the formulation containing the complex extract.

〈임상실험평가대상〉〈Clinical Experiment Evaluation Subject〉

표 8과 같이 분류된 모델그룹을 임상실험평가대상으로 선정하였다.Model groups classified as in Table 8 were selected for clinical trial evaluation.

모델그룹Model Group 모발의 상태Hair condition 제1그룹1st group 모발이 갈라지고, 뻣뻣하고, 푸석거리며 유연성이 떨어진 (육안평가시 30% 이상 진행중)20대부터 60대 남성 10명 Hair split, stiff, sloppy, and inflexible (more than 30% in visual evaluation) 10 men in their 20s and 60s 제2그룹2nd group 모발이 갈라지고, 뻣뻣하고, 푸석거리며 유연성이 떨어진 (육안평가시 30% 이상 진행중)20대부터 60대 남성 5명과 여성 11명 Hair splitting, stiffness, slackness and inflexibility (more than 30% in visual evaluation) 5 males and 11 females in their 20s and 60s 제3그룹3rd group 모발이 뻣뻣하고, 푸석거리며 유연성이 떨어진 (육안평가시 20% 이상 진행중)20대부터 60대 남성 5명과 여성 15명Hair stiff, sloppy, and inflexible (more than 20% in visual evaluation) 5 men in their 20s and 60s and 15 women 제4그룹4th group 육안평가시 건강한 모발인 18세부터 60대 남성 15명과 여성 20명In the visual evaluation, 15 healthy men and 20 women in their 60s, healthy hair

〈 임상실험평가결과〉<Clinical Trial Evaluation Results>

표 8의 모델그룹을 대상으로 실시예3의 헤어토닉, 실시예6의 샴푸, 실시예8의 트리트먼트를 계속 전달하면서 7일에 1회, 평균 2개월 동안 사용하고, 각 그룹에 대한 모발의 유연, 보습, 모발의 갈라짐 방지 효과를 확인하여 표 9에 나타내었다(임상실험평가에서의 점수는 각 그룹에 속한 모델의 개선된 효과상태를 상 : 8∼10점, 중 : 5∼7점, 하 : 0∼4점으로 나누고 이것를 각 모델그룹의 점수를 평균화 한 결과를 조성물에 대한 효과로 나타냈다).The hair tonic of Example 3, the shampoo of Example 6, and the treatment of Example 8 were continuously applied to the model groups of Table 8, once every 7 days for 2 months, and the hair of each group was The effects of softening, moisturizing, and hair splitting were confirmed and shown in Table 9. (Scores in the clinical trial evaluations indicate the improved effect states of the models belonging to each group. Lower: Divided by 0-4 points and averaged the scores of each model group as the effect on the composition).

모델그룹Model Group 유 연 효 과Yeon Yeon Effect 보 습 효 과Moisturizing effect 갈 라 짐 방 지 효 과Garage prevention effect 제 1 그 룹First group 8.7점8.7 points 7.9점7.9 points 8.0점8.0 points 제 2 그 룹Second group 8.4점8.4 points 7.5점7.5 points 6.7점6.7 points 제 3 그 룹Third group 8.8점8.8 points 7.0점7.0 points 6.8점6.8 points 제 4 그 룹Fourth group 8.1점8.1 points 7.2점7.2 points 7.1점7.1 points

표 9에 본 발명의 복합추출물이 함유된 헤어토닉, 샴푸, 트리트먼트를 사용한 임상실험 과정중 피부의 상태도 특이한 피부자극 소견이 발견되지 않으면서 두피 및 모발의 보습효과, 모발의 유연 및 갈라짐 방지 효과가 우수한 것으로 평가되었다.Table 9 shows the condition of the skin during the clinical experiment using the hair tonic, shampoo, and treatment containing the complex extract of the present invention, while no unusual skin irritation was found, the moisturizing effect of the scalp and hair, hair softness and cracking prevention. The effect was evaluated to be excellent.

특히, 파마 등으로 손상된 모발의 회복효과도 매우 우수한 것으로 평가되었다.In particular, it was evaluated that the recovery effect of hair damaged by the perm and the like is also very good.

또한, 본 조성물의 두피 및 모발의 보습효과, 모발의 유연 및 갈라짐 방지 효과 실험에 있어서, 복합추출물의 함량은 제형을 유지 할수 있는 범위에서 사용농도 제한은 0.15 ∼5.00 % 로 제한을 두며, 중량을 높여도 피부발작등의 부작용이 전혀 나타나지 않은 것으로 효과가 우수한 것으로 평가되었다.In addition, in the experiment of the moisturizing effect of the scalp and hair of the present composition, the softening and cracking prevention effect of the hair, the content of the complex extract is limited to 0.15 to 5.00% in the range that can maintain the formulation, and the weight Even if it increased, the side effect such as skin attack did not appear at all, and the effect was evaluated as being excellent.

또한, 장기간 사용을 해도 피부 발작 등의 부작용이 나타나지 않는 두피 및 모발의 보습효과, 모발의 유연 및 갈라짐 방지 효과가 우수한 것으로 사료된다.In addition, long-term use is believed to be excellent in moisturizing effect of the scalp and hair, hair softness and cracking prevention effect does not appear side effects such as skin attack.

Claims (5)

유효성분으로서 산수국잎추출물, 아르니카몬타나꽃추출물, 회향추출물, 황금추출물, 마트리카리아꽃추출물, 모란뿌리추출물, 살비아추출물, 포트마리골드꽃추출물이 혼합된 복합추출물을 두피 및 모발용 제형의 총 중량을 기준으로 0.15∼5.00 중량%로 함유하는 것을 특징으로 두피 및 모발의 개선효과 활성을 갖는 조성물.The total weight of the formulation for the scalp and hair is mixed with a wild hydrangea leaf extract, arnica montana flower extract, fennel extract, golden extract, matricaria flower extract, peony root extract, salvia extract, and port marigold flower extract. 0.15 to 5.00% by weight based on the composition having the effect of improving the scalp and hair. 삭제delete 청구항 1에 있어서, 티로시나제 활성촉진제, 침투촉진제, 혈류촉진제, 모포부활제 또는 5α-리덕타제 억제제, 두피영양제, 가려움억제제, 용해보조제, 용제, 계면활성제, 보습제, 점증제, 방부제, 산화방지제, 금속이온봉쇄제, 항염증제, 항미생물제, 계면활성제, 살균제, 착색제, 착향제를 1가지 또는 2가지 이상 더 포함하는 것을 특징으로 하는 두피 및 모발의 개선효과 활성을 갖는 조성물.The method of claim 1, a tyrosinase activator, a penetration enhancer, a blood flow promoting agent, a blanket activator or a 5α-reductase inhibitor, a scalp nutrient, an itch inhibitor, a dissolution aid, a solvent, a surfactant, a humectant, a thickener, a preservative, an antioxidant, a metal A composition having an improving effect of the scalp and hair, characterized in that it comprises one or more of an ion blocker, an anti-inflammatory agent, an antimicrobial agent, a surfactant, a bactericide, a colorant, and a flavoring agent. 삭제delete 삭제delete
KR1020180096659A 2018-08-20 2018-08-20 Composition having improvement activity of scalp and hair using compound extract KR102083003B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180096659A KR102083003B1 (en) 2018-08-20 2018-08-20 Composition having improvement activity of scalp and hair using compound extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180096659A KR102083003B1 (en) 2018-08-20 2018-08-20 Composition having improvement activity of scalp and hair using compound extract

Publications (1)

Publication Number Publication Date
KR102083003B1 true KR102083003B1 (en) 2020-02-28

Family

ID=69638176

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180096659A KR102083003B1 (en) 2018-08-20 2018-08-20 Composition having improvement activity of scalp and hair using compound extract

Country Status (1)

Country Link
KR (1) KR102083003B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102205789B1 (en) * 2020-09-08 2021-01-21 주식회사 스킨오르 Extermal composition for preventing hair loss containing extracts derived from natural products and method for manufacturing the same
KR102268243B1 (en) * 2020-08-19 2021-06-24 주식회사 제이에스무역 A hair care composition comprising egg yolk oil

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09221413A (en) * 1996-02-14 1997-08-26 Noevir Co Ltd Hair tonic
JP2005255611A (en) * 2004-03-11 2005-09-22 Ryuei Soken:Kk Hair growing tonic and anti-depilatory agent
KR100966902B1 (en) * 2009-08-25 2010-06-30 (주)엘큐어 Treatment for health of hair
KR20160081204A (en) * 2014-12-31 2016-07-08 (주)아모레퍼시픽 Composition for improving hair and scalp condition coprising extract of hydrangea serrata

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09221413A (en) * 1996-02-14 1997-08-26 Noevir Co Ltd Hair tonic
JP2005255611A (en) * 2004-03-11 2005-09-22 Ryuei Soken:Kk Hair growing tonic and anti-depilatory agent
KR100966902B1 (en) * 2009-08-25 2010-06-30 (주)엘큐어 Treatment for health of hair
KR20160081204A (en) * 2014-12-31 2016-07-08 (주)아모레퍼시픽 Composition for improving hair and scalp condition coprising extract of hydrangea serrata

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102268243B1 (en) * 2020-08-19 2021-06-24 주식회사 제이에스무역 A hair care composition comprising egg yolk oil
KR102205789B1 (en) * 2020-09-08 2021-01-21 주식회사 스킨오르 Extermal composition for preventing hair loss containing extracts derived from natural products and method for manufacturing the same

Similar Documents

Publication Publication Date Title
US8715714B2 (en) Uses of rare earth elements for hair improvement
KR101121328B1 (en) Improvement composite of scalp and hair be contain yeast, gold, propolis, ginseng, purslane, clove, pleuropterus multiflorus
KR101017709B1 (en) Cosmetic composition comprising the herbal mixed extract comprising panax ginseng c.a meyer showing hair-growth stimulating activity and preventing activity from hair loss
KR101196523B1 (en) Composition for promoting hair growth comprising fermented oriental medicine extract
EP2066289A1 (en) Uses of rare earth elements for hair improvement
KR20090095359A (en) Hair compositions comprising an extract of griffonia simplicifolia and an extract of charnaecyparis obtusa
KR101091002B1 (en) Composition for improving condition of hair and scalp with function of preventing depilation and accelerating hair growth using natural extracts
KR102083003B1 (en) Composition having improvement activity of scalp and hair using compound extract
KR19990018331A (en) Hair growth promoting composition
KR20080073458A (en) Cosmetics composition contain of trifolium repens, ptunus armeniaca, panax ginseng c,a meyer for hair conditioning
KR20030036536A (en) composite that have improvement effect vitality of scalp and hair
EP0914816A1 (en) Scalp care compositions
KR100534483B1 (en) Composition for improving state of scalp and hair comprising Panax ginseng C.A Meyer, Swertia japonica Makino, Cnidium Officinale Makino, Paeonia suffruticosa Andrews and Belamcanda chinensis De Candolle
KR101598083B1 (en) An antifungal composition comprising an natural fermentation material
JP6083938B2 (en) Hair cosmetics
JP2000212057A (en) Cosmetic composition
US20070207114A1 (en) Hair Growth Agent Composition
KR101692910B1 (en) Composition for relieving seborrheic dermatitis and method for manufacturing thereof
JP2020176064A (en) Composition for hair growth
KR101131685B1 (en) Cosmetic compositions having sebosuppressive effect
KR20100029807A (en) Natural herbal composition for the prevention of depilation and improvement of hair growth and method for preparing the same
KR101456655B1 (en) Preventing and Treating Composition for dandruff and itchy scalp
US11571382B1 (en) Herbal shampoo composition and method for preparing the same
KR101973638B1 (en) Composition for improving condition of hair and scalp containing extract of soybean leaf
KR102373929B1 (en) Cosmetics composition for scalp care in natural shampoo and essence comprising mixed ferment extracts of natural products

Legal Events

Date Code Title Description
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant